By Admin at 16 Dec 2015
About 80 percent of pancreatic cancer patients are missing out on an important blood test that could help them make important treatment decisions.
By Admin at 9 Dec 2015
One of the main hurdles to increasing outcomes among ovarian cancer patients is resistance to chemotherapy. It’s estimated that 75 percent of women with advanced ovarian cancer initially respond to chemotherapy treatment, but the majority will relapse within two years.
By Admin at 7 Dec 2015
Chemotherapy is one of the most common treatments for many types of cancer, but not all tumors will respond to the medications. A new study published in Cancer Cell has revealed a new mechanism that may be driving chemo-resistance.
By Admin at 2 Dec 2015
Advanced breast cancer is considered incurable, but some patients may benefit from chemotherapy, hormone therapy or other systemic treatments. Complete remission and long-term survival are possible for some patients, particularly if new consensus guidelines are followed for treatment.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial